Burotto M, Zvirbule Z, Mochalova A, Runglodvatana Y, et al. Corrigendum to 'IMscin001 Part 2: a randomised phase III, open-label, multicentre study examining the pharmacokinetics, efficacy, immunogenicity, and safety of atezolizumab subcutaneous versus intravenous administration in previously treated locally a Ann Oncol 2024 Jan 8:S0923-7534(23)05112-8. doi: 10.1016/j.annonc.2023.
PMID: 38195363